The BIOTEK2021 programme is the Research Council of Norway’s most comprehensive research initiative in the field of biotechnology. The programme will run from 2012 through 2021.
The BIOTEK21 programme succeeds the Programme on Functional Genomics in Norway (FUGE), which was concluded in 2011.
All types of cancer begin with genetic aberrations in the DNA of normal cells. An extensive research project will examine the errors occurring in the genes of several thousand Norwegian patients. The objective is to develop treatment that is better adapted to the individual patient.
European Research Area Network, Coordinating Action in Plant Sciences (ERA-CAPS) har lansert sin første felles utlysning.
The Research Council of Norway recently launched its new large-scale initiative for biotechnology: Biotechnology for innovation (BIOTEK2021). The programme replaces the Programme on Functional Genomics in Norway (FUGE).